If You Invested in Delivra Health (DHBUF)

Delivra Health Brands Inc. (OTCQB: DHBUF; TSXV: DHB) is a consumer packaged goods company in the health and wellness sector. According to the company, its portfolio features the brands Dream Water® and LivRelief™, which are focused on delivering relief from common everyday issues such as sleeplessness, chronic pain and anxiety. Delivra Health describes its purpose as helping people take control of their health with alternative wellness solutions, and notes that its products have allowed many customers to reclaim their mobility, energy, and quality of life.

Business focus and brand portfolio

Delivra Health positions itself as a health and wellness consumer products company built around two core brands. Dream Water® is presented as a sleep-support brand, while LivRelief™ focuses on relief from chronic pain and related concerns. Across multiple press releases, the company emphasizes that both brands are central to its strategy and that they address recurring, everyday health challenges such as sleeplessness, anxiety and chronic pain.

The company repeatedly refers to itself as a consumer packaged goods company, highlighting that it sells finished branded products rather than raw materials. It also notes that the websites of its two subsidiaries are associated with Dream Water® and LivRelief™, underscoring that these brands are organized as distinct business units under the Delivra Health umbrella.

Health and wellness positioning

Delivra Health states that its team is energized by helping people take control of their health through alternative wellness solutions. In its public communications, the company links Dream Water® and LivRelief™ to relief from sleeplessness, chronic pain and anxiety, and it frames these conditions as common everyday issues. This positioning places Delivra Health within the broader health and wellness market, with a focus on over-the-counter style solutions rather than prescription pharmaceuticals.

The company also highlights that its products have allowed customers to reclaim mobility and energy, connecting symptom relief with improved quality of life. This narrative appears consistently in its "About Delivra Health Brands Inc." sections across multiple news releases.

Markets and channels

Delivra Health reports activity in both the United States and Canada for its Dream Water® and LivRelief™ brands. In its financial updates, the company refers to Dream Water® USA and Dream Water® Canada, and discusses performance in e-commerce and retail channels. It also notes that LivRelief™ Canada has achieved growth in its e-commerce channel.

Beyond North America, Delivra Health has disclosed that its Dream Water® brand is expanding into Middle Eastern markets. The company has announced the launch of 60-count Sleep Gummies and 6-count Sleep Gummies into Middle Eastern markets through regional distributors, and has specifically referenced the Gulf Cooperation Council (GCC) region and a distributor based in Kuwait, as well as collaboration with a distribution partner in Saudi Arabia. These disclosures indicate that Delivra Health is pursuing international distribution for Dream Water® through local partners.

Product formats and brand development

Within the Dream Water® brand, Delivra Health has described several product formats. The company has discussed Dream Water® Sleep Shots, including a Snoozeberry Sleep Shot format, and has highlighted the introduction of Sleep Gummies in both 60-count and 6-count packages. It has indicated that 60-count Sleep Gummies were launched in Canada and later extended into Middle Eastern markets, and that 6-count Sleep Gummies are being introduced in Canada and the GCC region to support convenience and travel-oriented channels.

For LivRelief™, Delivra Health refers to over-the-counter LivRelief™ products and a licensed LivRelief™ Infused business. It distinguishes between LivRelief™ Non-Infused and licensed LivRelief™ Infused products in its financial commentary, noting that it is evaluating and revising the route-to-market strategy for the licensed LivRelief™ Infused channel. The company has also referenced a marketing campaign for LivRelief™ under the theme "Quiets Chronic Pain" and has reported growth in units sold for LivRelief™ products.

Distribution relationships and brand visibility

Delivra Health has described several distribution and channel relationships for its brands. For Dream Water®, the company has announced a partnership with QVC, a televised and online shopping network in the United States, under which QVC offers a 16-pack of Dream Water Snoozeberry Sleep Shots. The company has also indicated that Dream Water® products, including Sleep Shots and Sleep Gummies, are available through distributors, retailers and e-commerce channels.

In Canada, Delivra Health has stated that Dream Water® products are available through established retail and e-commerce distribution partners. It has mentioned that Dream Water® offerings, including Sleep Shots and Sleep Gummies, are available in accounts such as Shoppers Drug Mart, Loblaws, Circle K and airport channels. For Middle Eastern markets, the company has referenced local distributors in Kuwait and Saudi Arabia that are responsible for launching Dream Water® Sleep Gummies in their respective markets.

Financial reporting and performance indicators

Delivra Health regularly reports financial and operating results, including net revenue, gross profit, gross profit margin, and expenses such as general and administration and sales and marketing. The company also discloses a non-IFRS measure, Adjusted EBITDA, which it defines as profit or loss from operations before interest, taxes, depreciation and amortization and adjusted for items such as share-based compensation, inventory write-downs, and other non-cash items. Management states that Adjusted EBITDA is used to analyze core operating performance and to compare profitability among companies and industries.

In its fiscal 2025 and Q1 2026 disclosures, Delivra Health has highlighted year-over-year net revenue growth, changes in gross profit and gross margin, and shifts in expense levels driven by marketing campaigns and digital marketing programs. It has also noted periods of positive Adjusted EBITDA and described how investments in marketing, innovation and sales programs affect this measure.

Marketing and brand-building initiatives

The company places emphasis on marketing and consumer promotional programs as a driver of growth for Dream Water® and LivRelief™. It has reported launching major marketing campaigns, including "Shush Your Mind" for Dream Water® and "Quiets Chronic Pain" for LivRelief™, and has associated these campaigns with increased brand awareness, engagement and unit sales. Delivra Health has also described strategic marketing initiatives as supporting both short-term sales objectives and longer-term brand-building efforts.

In its commentary, management links increased sales and marketing investments to expanded customer bases, new product listings and broader distribution. The company notes that these efforts contribute to revenue growth but can also affect short-term profitability measures such as Adjusted EBITDA.

Strategic themes and company outlook (as stated by the company)

Across its public statements, Delivra Health emphasizes several recurring themes: growth of its core brands Dream Water® and LivRelief™, expansion of e-commerce and retail channels, international distribution for Dream Water®, and refinement of the licensed LivRelief™ Infused route-to-market strategy. Management commentary refers to building recurring consumer demand through innovation, marketing and channel diversification, and to strengthening the foundation for sustainable long-term performance.

The company also refers to opportunities for global expansion and a pipeline of new products within its brands. While specific forward-looking statements are subject to the usual cautions noted in its news releases, these themes illustrate how Delivra Health describes its strategic focus to investors and stakeholders.

Regulatory and risk disclosures

Delivra Health’s news releases reference risk disclosures contained in its annual information form and management’s discussion and analysis documents filed on SEDAR+. The company highlights that non-IFRS measures such as Adjusted EBITDA do not have standardized meanings and may not be comparable to similar measures presented by other companies. It advises that such measures should be considered in conjunction with IFRS financial measures presented in its financial statements.

Frequently asked questions about Delivra Health Brands Inc.

The following FAQs summarize key points based on the company’s public disclosures.